Managing Dyspnea in Advanced Chronic Obstructive Pulmonary Disease: Balancing All the Evidence
- 1 July 2015
- journal article
- Published by Oxford University Press (OUP) in Annals of the American Thoracic Society
- Vol. 12 (7) , 978-980
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Effects of Opioids on Breathlessness and Exercise Capacity in Chronic Obstructive Pulmonary Disease. A Systematic ReviewAnnals of the American Thoracic Society, 2015
- Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective studyBMJ, 2014
- Stakeholder Priorities for Comparative Effectiveness Research in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Opioid therapy for refractory dyspnea in patients with advanced chronic obstructive pulmonary disease: patients' experiences and outcomesCMAJ Open, 2013
- Once-Daily Opioids for Chronic Dyspnea: A Dose Increment and Pharmacovigilance StudyJournal of Pain and Symptom Management, 2011
- Managing Dyspnea in Patients with Advanced Chronic Obstructive Pulmonary Disease: A Canadian Thoracic Society Clinical Practice GuidelineCanadian Respiratory Journal, 2011
- Understanding Breathlessness: Cross-Sectional Comparison of Symptom Burden and Palliative Care Needs in Chronic Obstructive Pulmonary Disease and CancerJournal of Palliative Medicine, 2010
- Palliation of dyspnoea in advanced COPD: revisiting a role for opioidsThorax, 2009
- An Official American Thoracic Society Clinical Policy Statement: Palliative Care for Patients with Respiratory Diseases and Critical IllnessesAmerican Journal of Respiratory and Critical Care Medicine, 2008
- A systematic review of the use of opioids in the management of dyspnoeaThorax, 2002